Lymphoma & Plasma Cell Disorders

News

EC approves mogamulizumab for MF, SS

The European Commission (EC) has granted marketing authorization for mogamulizumab (Poteligeo), a humanized monoclonal antibody directed against...

News

Pegfilgrastim biosimilar approved by EC

The European Commission (EC) has granted marketing authorization for Sandoz’s pegfilgrastim product Ziextenzo®, a biosimilar of Amgen’s Neulasta...

News

EC approves pegfilgrastim biosimilar

The European Commission (EC) has approved Mundipharma’s pegfilgrastim product Pelmeg, a biosimilar of Amgen’s Neulasta. Pelmeg is approved for...

News

CAR T-cell studies to be presented at ASH

Several studies set to be presented at the 2018 ASH Annual Meeting provide new insights regarding chimeric antigen receptor (CAR) T-cell therapies...

Pages